Journal article
Kinase inhibitors: A new tool for the treatment of rheumatoid arthritis
Clinical immunology (Orlando, Fla.), v 148(1), pp 66-78
01 Jul 2013
PMID: 23651870
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Despite aggressive immunosuppression with biologics and traditional DMARDs, achieving disease remission remains an unmet goal for most rheumatoid arthritis (RA) patients. In this context, there is a demand for novel treatment strategies, with kinase inhibitors expected to enrich the existing therapeutic armamentarium. In RA some kinases participate in the generation of pathogenic signaling cascades. Pharmacologic inhibition of kinases that mediate pathogenic signal transduction heralds a new era for RA therapeutics. Oral inhibitors of JAKs, Syk, PI3Ks, MAPKs and Btk are under development or in clinical trials in patients with RA. In this review, we discuss the scientific rationale for the use of kinase inhibitors in RA and summarize the experience from clinical trials.
•Kinases are rationale therapeutic targets given their downstream signaling effects.•The Jak inhibitor tofacitinib was recently approved for RA.•Syk inhibition with fostamatinib shows promise in clinical studies.•Targeting PI3Ks, Btk and upstream of p38 MAPK represent future advances.•Abrogation of homeostatic pathways compromises benefits of some kinase inhibitors.
Metrics
Details
- Title
- Kinase inhibitors: A new tool for the treatment of rheumatoid arthritis
- Creators
- Soumya D. Chakravarty - Hospital for Special SurgeryPoulikos I. Poulikakos - Icahn School of Medicine at Mount SinaiLionel B. Ivashkiv - Hospital for Special SurgeryJane E. Salmon - Hospital for Special SurgeryGeorge D. Kalliolias - Cornell University
- Publication Details
- Clinical immunology (Orlando, Fla.), v 148(1), pp 66-78
- Publisher
- Elsevier
- Number of pages
- 13
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Rheumatology; General Internal Medicine
- Web of Science ID
- WOS:000320427300008
- Scopus ID
- 2-s2.0-84877355643
- Other Identifier
- 991021930449004721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Immunology